Sheervalilou et al., 2020 - Google Patents
A review on microRNAs' function, detection and evaluation methods, expression dysregulation mechanisms and possible applications in clinical phase as diagnostic …Sheervalilou et al., 2020
View PDF- Document ID
- 6799797339934067336
- Author
- Sheervalilou R
- Shahraki J
- Shahraki O
- Shirvalilou S
- Ghaznavi H
- Publication year
- Publication venue
- Razi Journal of Medical Sciences
External Links
Snippet
MicroRNAs are small endogenous single-stranded non-protein-coding RNAs that often act as negative gene regulators at post-transcriptional level. These molecules actively participate in a wide variety of cellular events, and are involved in pathogenesis of different …
- 229920001239 microRNA 0 title abstract description 21
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/10—Production naturally occurring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/31—Combination therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sadri Nahand et al. | microRNAs: Key players in virus‐associated hepatocellular carcinoma | |
| Sethi et al. | MicroRNAs and head and neck cancer: reviewing the first decade of research | |
| Mansoori et al. | Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy | |
| Wang et al. | Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy | |
| Dahiya et al. | MicroRNAs in ovarian carcinomas | |
| ES2536422T3 (en) | Methods and compositions based on microRNA for the diagnosis and treatment of pancreatic cancer | |
| Liu et al. | MicroRNA profiling and head and neck cancer | |
| Hummel et al. | MicroRNAs: predictors and modifiers of chemo-and radiotherapy in different tumour types | |
| Rachagani et al. | Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer | |
| Nohata et al. | MicroRNAs function as tumor suppressors or oncogenes: aberrant expression of microRNAs in head and neck squamous cell carcinoma | |
| Babashah et al. | The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis | |
| ES2429404T3 (en) | MicroRNA-based procedures for the diagnosis and prognosis of lung cancer | |
| ES2446362T3 (en) | Traces of microRNA during human megakaryocytogenesis | |
| Guancial et al. | The evolving understanding of microRNA in bladder cancer | |
| US9821009B2 (en) | Method for modulating microRNA content in living beings and the use thereof | |
| CN102218144B (en) | A kind ofly regulate method of miRNA content in organism and uses thereof | |
| US20100298407A1 (en) | Compositions and methods featuring micronas for treating neoplasia | |
| JP2008519606A5 (en) | ||
| JP2010538653A5 (en) | ||
| Wang et al. | MicroRNA expression detection methods | |
| Song et al. | Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis | |
| Carron et al. | microRNAs deregulation in head and neck squamous cell carcinoma | |
| Fiorucci et al. | Cancer regulator microRNA: potential relevance in diagnosis, prognosis and treatment of cancer | |
| Torres et al. | MicroRNAs and their role in gynecological tumors | |
| Li et al. | The expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinoma |